TY - JOUR
T1 - Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE)
T2 - A multicenter randomized controlled study. Protocol and statistical analysis plan
AU - Cabrini, Luca
AU - Brusasco, Claudia
AU - Roasio, Agostino
AU - Corradi, Francesco
AU - Nardelli, Pasquale
AU - Filippini, Matteo
AU - Cotticelli, Virginia
AU - Belletti, Alessandro
AU - Ferrara, Lorenzo
AU - Antonucci, Elio
AU - Baiardo Redaelli, Martina
AU - Lattuada, Marco
AU - Colombo, Sergio
AU - Olper, Luigi
AU - Ponzetta, Giuseppe
AU - Ananiadou, Sofia
AU - Monti, Giacomo
AU - Severi, Luca
AU - Maj, Giulia
AU - Giardina, Giuseppe
AU - Biondi-Zoccai, Giuseppe
AU - Benedetto, Umberto
AU - Gemma, Marco
AU - Cavallero, Sarah Sophia Michelle
AU - Hajjar, Ludhmila Abrahao
AU - Zangrillo, Alberto
AU - Bellomo, Rinaldo
AU - Landoni, Giovanni
PY - 2019/3
Y1 - 2019/3
N2 - Objective: Few randomized trials have evaluated the use of non-invasive ventilation (NIV) for early acute respiratory failure (ARF) in non-intensive care unit (ICU) wards. The aim of this study is to test the hypothesis that early NIV for mild-moderate ARF in non-ICU wards can prevent development of severe ARF. Design: Pragmatic, parallel group, randomized, controlled, multicenter trial. Setting: Non-intensive care wards of tertiary centers. Patients: Non-ICU ward patients with mild to moderate ARF without an established indication for NIV. Interventions: Patients will be randomized to receive or not receive NIV in addition to best available care. Measurements and main results: We will enroll 520 patients, 260 in each group. The primary endpoint of the study will be the development of severe ARF. Secondary endpoints will be 28-day mortality, length of hospital stay, safety of NIV in non-ICU environments, and a composite endpoint of all in-hospital respiratory complications. Conclusions: This trial will help determine whether the early use of NIV in non-ICU wards can prevent progression from mild-moderate ARF to severe ARF.
AB - Objective: Few randomized trials have evaluated the use of non-invasive ventilation (NIV) for early acute respiratory failure (ARF) in non-intensive care unit (ICU) wards. The aim of this study is to test the hypothesis that early NIV for mild-moderate ARF in non-ICU wards can prevent development of severe ARF. Design: Pragmatic, parallel group, randomized, controlled, multicenter trial. Setting: Non-intensive care wards of tertiary centers. Patients: Non-ICU ward patients with mild to moderate ARF without an established indication for NIV. Interventions: Patients will be randomized to receive or not receive NIV in addition to best available care. Measurements and main results: We will enroll 520 patients, 260 in each group. The primary endpoint of the study will be the development of severe ARF. Secondary endpoints will be 28-day mortality, length of hospital stay, safety of NIV in non-ICU environments, and a composite endpoint of all in-hospital respiratory complications. Conclusions: This trial will help determine whether the early use of NIV in non-ICU wards can prevent progression from mild-moderate ARF to severe ARF.
KW - Acute respiratory failure
KW - ARF
KW - NIV
KW - Non-invasive ventilation
UR - http://www.scopus.com/inward/record.url?scp=85061427183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061427183&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2019.02.001
DO - 10.1016/j.cct.2019.02.001
M3 - Article
C2 - 30739002
AN - SCOPUS:85061427183
SN - 1551-7144
VL - 78
SP - 126
EP - 132
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -